Robin LaChapelle insider trades

Open-market stock purchases and sales by Robin LaChapelle, Chief Operating Officer at ArriVent BioPharma, Inc, from SEC Form 4 filings since Sep 19, 2024.

Recent trades

DateStockTradeValue
Feb 2, 2026AVBP ArriVent BioPharma, IncBought (not open market)—

Companies traded

  • AVBP ArriVent BioPharma, Inc: other filings, last Feb 2, 2026

Get free alerts when Robin LaChapelle files a new trade →